NHLBI ARDS Network

Welcome to the NHLBI ARDS Clinical Network. For more information about the ARDS Clinical Network, please visit our about page.

Latest News

ARDSNet Data

Public de-identified data for open period studies:

For access to samples for the open period studies, please contact biorepository@nhlbi.nih.gov.

The ALTA and EDEN-Omega studies are still in their proprietary period; see the instructions below for information on using data and samples from these studies.

click to expand

Submitting a proposal for proprietary period studies:

Follow the application submission instructions for proposals listed in the Sub-study and Ancillary Study Process (updated Jan 2008) document.
Once you have received approval from the Pathogenesis Committee, submit a request for samples to the NHLBI Repository by following the instructions detailed on the NHLBI BioLINCC website: https://biolincc.nhlbi.nih.gov/home/ Note: this is not required for DNA-only proposals. You will need to include the Pathogenesis Committee approval letter from Dr. Hubmayr with your submission.
You will receive notification regarding approval of your request for samples from the BioLINCC group. Once you receive this notification, please use the ARDSNet Sample and Data Request Form to request samples and/or data. Your request will be received by the CCC who will assist you with acquiring samples from the SeraCare Biorepository as well as putting you together with a CCC statistician. (TEMPORARILY ON HOLD; PLEASE CONTACT Nancy Ringwood nringwood@partners.org AT THIS TIME).
Please direct questions to Rolf Hubmayr, Chair or Nancy Ringwood at the CCC.

Public Tools

H1N1 Information

The Office of the Assistant Secretary for Preparedness and Response within the US Department of Health and Human Services and the US Centers for Disease Control and Prevention have partnered with the NHLBI and the ARDSNet to establish an adult registry of critically ill novel influenza.